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ABSTRACT
Background and Objectives: Hysteroscopy offers diag-
nostic accuracy and the ability to treat uterine pathology,
but practitioners may be reluctant to perform it without
a high index of suspicion because it traditionally requires
an operating room. This study reviews the findings and
feasibility of office-based diagnostic and operative hys-
teroscopy in an unselected in vitro fertilization (IVF)
population to evaluate whether first-line hysteroscopy
should be recommended.
Methods: One thousand consecutive infertile patients
scheduled for in vitro fertilization underwent office hys-
teroscopy. A rigid 20-degree 5-mm hysteroscope, with an
operative channel for grasping forceps, scissors, or coax-
ial bipolar electrode was used. Operative findings, com-
plications, and patient tolerance were noted.
Results: Sixty-two percent of patients had a normal uter-
ine cavity. Thirty-two percent had endometrial polyps.
Other pathology included submucous fibroids (3%),
intrauterine adhesions (3%), polypoid endometrium
(0.9%), septum (0.5%) retained products of conception
(0.3%), and bicornuate uterus (0.3%). The pathology was
treated in all patients without complication.
Conclusions: When hysteroscopy is routinely per-
formed prior to in vitro fertilization, a significant per-
centage of patients have uterine pathology that may
impair the success of fertility treatment. Patient tolerance,
safety, and the feasibility of simultaneous operative cor-
rection make office hysteroscopy an ideal procedure.
Key Words: Reproductive surgery, Hysteroscopy, In
vitro fertilization, Endometrial polyps.
INTRODUCTION
In 2000, 99639 assisted reproductive technology cycles
were undertaken in the United States alone.1 With the
increasing utilization of intracytoplasmic sperm injection
and preimplantation genetic diagnosis along with the
increasing success of in vitro fertilization (IVF) per cycle,
more couples will turn to IVF to assist with conception.
Optimizing the first cycle is of paramount importance
given the high cost and time investment. Evaluation of
the uterine cavity prior to IVF has been commonly per-
formed by hysterosalpingography (HSG), despite its
inherent diagnostic limitations, use of radiation, and chal-
lenging scheduling requirements at some institutions.
Recently, sonohysterography (SHG) has been used by
many IVF programs as a more practical procedure to
evaluate the uterine cavity in an office setting. However,
hysteroscopy is generally accepted as the gold standard
in diagnosis and, more importantly, allows for treatment
of pathology at the same time. Practitioners may be
reluctant to perform hysteroscopy as an initial test with-
out a high degree of suspicion for pathology because it
has traditionally required anesthesia in an operating
room setting. The advent of smaller diameter instruments
makes office-based operative hysteroscopy an ideal first-
line procedure and can efficiently treat infertile patients
with uterine abnormalities in the same setting, thus facil-
itating a rapid transition from diagnosis to treatment and
subsequent pregnancy.
The objective of this study was to review office-based
diagnostic and operative hysteroscopic findings and
treatment in a large, unselected, IVF patient population
to evaluate whether first-line hysteroscopy should be rec-
ommended to these patients.
METHODS
One thousand consecutive infertile patients scheduled
for IVF underwent routine office hysteroscopy between
January 1998 and March 2003 by the senior author with
the assistance of a resident or fellow. All hysteroscopies
were performed using a rigid 20-degree 5-mm hystero-
scope with an operative channel for the use of grasping
forceps, scissors, or coaxial bipolar electrode. Instru-
ments were placed through the operative channel when
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needed for treatment of pathology after the diagnostic
portion had been completed. Typically, less than 1 liter
of normal saline was used as the distention media for
procedures, except myomectomies, which occasionally
required larger volumes. For these longer cases, fluid bal-
ance was monitored by ancillary staff throughout the pro-
cedure. Diagnostic findings, operative outcomes, compli-
cations, and patient tolerance during the procedure were
noted.
The coaxial bipolar electrode surgical system (Versapoint,
Gynecare, Sommersville, NJ) was used for myomec-
tomies. Power settings were from 60 W (desiccation) to
130 W (cutting). Typically, hysteroscopies were per-
formed during the oral contraceptive phase prior to con-
trolled ovarian hyperstimulation for IVF. Patients received
oral premedication with diazepam, intramuscular analge-
sia with meperidine, and a paracervical block with 1%
lidocaine until the last year of the study when an alter-
native regimen of diazepam, oral acetaminophen with
hydrocodone, intramuscular ketorolac, and a paracervical
block with 1% lidocaine was used. Eleven patients
requested conscious sedation with intravenous fentanyl
and midazolam in place of the above regimen.
To  minimize potential complications and to perform a
complete infertility evaluation, all patients had a trans-
vaginal ultrasound performed in the office prior to the
procedure to screen for uterine pathology, including uter-
ine anomalies and intramural or subserosal fibroids, as
well as to assess uterine position. Those patients with an
anteverted uterus had a full bladder at the time of hys-
teroscopy to facilitate placement of the hysteroscope.
Patients with known uterine fibroids greater than 1.5 cm
in size were excluded from the study because they were
treated in the operating room setting.
Each patient signed the appropriate informed consent for
the treatment received. Institutional review board
approval was obtained for review of patient charts and
clinic records.
RESULTS
Table 1 lists the findings, both normal and pathologic, of
the 1000 office hysteroscopies performed. Eleven patients
had more than one abnormality. All procedures were per-
formed without complications. Treatment of adhesions
and removal of polyps and submucous fibroids were
undertaken and completed in all patients. Division of
septi was performed in patients with a known single fun-
dus confirmed by laparoscopy at a prior time. No proce-
dures were aborted secondary to patient intolerance.
DISCUSSION
The basic infertility workup has traditionally included a
hysterosalpingogram to evaluate both the uterine cavity
and tubal patency. Although this test is fairly simple to
perform, it does not allow for simultaneous correction of
presumed uterine pathology. Additionally, previous stud-
ies have shown that HSG may miss from 30% to 40% of
uterine abnormalities.2-4 Given the high false-negative
rate, the low positive predictive value,5 and the inability
to treat abnormal findings concurrent with diagnosis,
HSG has significant limitations when evaluating the
endometrial cavity.
Sonohysterography has been proposed as a better diag-
nostic test of the uterine cavity. However, it also suffers
from a sensitivity and specificity inferior to that of hys-
teroscopy in most studies.6 Additionally, it does not allow
for correction of presumed pathology. Despite these
drawbacks, many IVF clinics use SHG rather than hys-
teroscopy for cavity evaluation. Perhaps because hys-
teroscopy has traditionally required general anesthesia in
an operating room setting, physicians do not consider
hysteroscopy as a first-line test. Additionally, distention
media are typically hypotonic and electrolyte-free for
operative work and thus require careful surveillance of
fluid status to minimize complications of hyponatremia
and fluid overload. These requirements have made many
practitioners reluctant to perform operative hys-
teroscopy.
Table 1.
Findings of 1000 Office Hysteroscopies Prior to IVF
Findings Cases
Normal Findings 618 (62%)
Endometrial Polyps 323 (32%)
Submucous Fibroids 27 (3%)
Intrauterine Adhesions 25 (3%)
Polypoid Endometrium 9 (0.9%)
Septum 5 (0.5%)
Bicornuate uterus 3 (0.3%)
Retained Products of conception 3 (0.3%)
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dilation and yet still allow for an operative channel are
available. Patient tolerance of hysteroscopes up to 5 mm
allows for their use in an office setting where anesthesia
is not required. Additionally, office-based hysteroscopy is
no more costly than HSG at many institutions. At our
medical center, the institutional and professional fees for
performing and reading a hysterosalpingogram are 30%
higher than the cost of an office hysteroscopy. Although
SHG may offer a cost reduction, for the many patients in
whom pathology is found or suspected, a hysteroscopy
is then indicated adding expense, delay, and inconven-
ience. Furthermore, if HSG or SHG misses pathology, the
cost of a first-line hysteroscopy that would have detect-
ed and treated such pathology pales in comparison to
the expense of a failed IVF cycle.
When evaluating a patient prior to IVF, examination of
the uterine cavity should be performed in the most accu-
rate manner. It has been reported that up to 50% of infer-
tile patients6-8 have uterine abnormalities, including
fibroids, polyps, intrauterine adhesions, and uterine mal-
formations. This is in agreement with our current study
that found 38% of IVF patients undergoing routine hys-
teroscopy had uterine pathology. The high incidence of
endometrial polyps in our patient population may be
related to multiple factors. Prior therapy with
gonadotropins exposes patients to higher levels of estro-
gen. These elevated estrogen levels may predispose
women to the development of endometrial polyps. In the
context of IVF, lower pregnancy rates have been report-
ed in the presence of uterine cavity abnormalities,9-11 and
their correction has been associated with improved preg-
nancy rates.8 Because pathology is present in 40% to 50%
of infertile patients, as mentioned previously, practition-
ers should be more inclined to recommend hysteroscopy
as part of a basic IVF workup because it allows for simul-
taneous operative management.
Outpatient hysteroscopy has been shown to be easily
performed with excellent surgical results in previous
studies. Nagele et al12 and Vercellini et al13 found com-
parable success rates of 98% for performing the proce-
dure. We were able to perform all diagnostic and opera-
tive procedures undertaken in the office setting. The ini-
tial office transvaginal ultrasound allowed us to exclude
patients with large fibroids (greater than 1.5 cm) or major
uterine malformations (requiring concurrent laparoscop-
ic surgery) from the study and to perform their surgery
in the operating room instead. Additionally, by using a 5-
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mm hysteroscope with a 5 F operative channel, all of the
desired instruments for operative correction can be used.
Grasping forceps allow for targeted removal of polyps
with the ability to retain a clean specimen for patholog-
ic confirmation. Scissors can be introduced for adhesions
and septi. The coaxial bipolar electrode with a choice of
differing tips allows for detailed uterine work, especially
in removing submucous fibroids. By using the cutting
mode primarily, and the desiccation mode when specif-
ic blood vessels are encountered, preservation of the del-
icate endometrium can occur while minimizing the risk
of postoperative adhesions.14 Patient tolerance of the
electrosurgical equipment was excellent, confirming
what Fernandez et al,15 Bettochi et al,16 and Guida et al17
found in their studies on outpatient hysteroscopy.
Office-based operative hysteroscopy has also been found
to be extremely safe. In our study, no complications
occurred, and no patients needed extended monitoring
or laboratory studies for fluid overload. Typical compli-
cations associated with hysteroscopy may be procedure-
related, media-related, or postprocedure related.18
Procedure-related complications, such as uterine perfo-
ration, cervical laceration, and damage to tissues includ-
ing bowel, bladder, and vagina, can be minimized by
performing an ultrasound prior to the procedure, reveal-
ing the subtle tortuosity and dimensions of the cervical
and endometrial canal. Asking the patient to have a full
bladder also helps to straighten the cervico-uterine canal
to facilitate entry in patients with an anteverted uterus.
For the rare patient with a difficult entry, concurrent
ultrasound guidance can be invaluable. Our clinic has an
ultrasound machine located in the procedure room and
readily available.
Using saline as the distention medium also serves to min-
imize (and often to eliminate) medium-related complica-
tions. Hyponatremia and cerebral edema are more of a
concern when using hypotonic, electrolyte-free media,
such as glycine or sorbitol. But as several authors14,18
point out, fluid overload, pulmonary edema, and con-
gestive heart failure can still occur if an excessive volume
of saline is used, especially if patients have underlying
medical conditions predisposing them to fluid-related
complications. Air embolism is also a potential compli-
cation that must be considered. By avoiding the
Trendelenburg position, excessive fluid pressure, pro-
longed operative times, a dilated cervix without instru-
ments sealing air entry, and by purging the tubing of air,
the risk of embolism is minimal.18
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Postprocedure complications like endometritis can be
reduced or eliminated by pre- and posttreatment with
antibiotics, as we do in our clinic, and by avoiding oper-
ating on patients with active vaginal infections.
Additional benefits of operative hysteroscopy have also
been proposed. Cervical dilatation may facilitate embryo
transfer and the introduction of insemination catheters.
McManus et al19 found this to be the case if cervical
dilatation was performed on average 31 days before
embryo transfer. However, in a previous study at our
institution, operative hysteroscopy in the cycle prior to
embryo transfer did not alter the percentage of transfers
that changed from difficult to easy although it was asso-
ciated with a higher pregnancy rate. The increase in preg-
nancy rates was attributed to the removal of endometrial
polyps or polypoid endometrium at the time of hys-
teroscopy and thus improving implantation in this popu-
lation at risk.8 Takahashi et al20 has also suggested that
irrigation of the cavity with saline may have a beneficial
effect on implantation and pregnancy rates in patients
with tubal or uterine causes of infertility. Regardless of
whether these adjunctive benefits are confirmed by fur-
ther study, office-based operative hysteroscopy still holds
value as the gold standard of diagnostic procedures for
uterine cavity abnormalities with the ease, safety, and
efficiency of simultaneous therapeutic correction of
abnormalities.
CONCLUSION
In an infertile population where hysteroscopy is per-
formed routinely prior to IVF, a significant percentage of
patients are found to have uterine pathology. Endometrial
polyps are found most frequently, with smaller numbers
of fibroids, adhesions, retained products of conception,
and septi. These abnormalities may impair the success of
future treatment cycles, and removal of the pathology is
recommended. Patient tolerance and the feasibility of
operative management, simultaneous with diagnosis,
make office-based operative hysteroscopy an ideal first-
line procedure with minimal risk to the patient.
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